Efficacy and safety of Xiyanping injection in the treatment of COVID ‐19: A multicenter, prospective, open‐label and randomized controlled trial
Xin‐yi Zhang, Lang Lv, Yu‐long Zhou, Liang‐dong Xie, Qin Xu, Xiao‐fan Zou, Yan Ding, Jie Tian, Jia‐liang Fan, Hai‐wei Fan, Yi‐xi Yang, Xiao‐qun Ye
Phytotherapy Research, doi:10.1002/ptr.7141
Xiyanping (XYP) is a Chinese herbal medicine used in the clinic to treat respiratory infection and pneumonia. Recent evidence identified XYP as a potential inhibitor of severe acute respiratory syndrome coronavirus 2, implying XYP as a possible treatment for the coronavirus disease 2019 . Here, we conducted a prospective, multicenter, open-label and randomized controlled trial to evaluate the safety and effectiveness of XYP injection in patients with mild to moderate COVID-19. We consecutively recruited 130 COVID-19 patients with mild to moderate symptoms from five study sites, and randomized them in 1:1 ratio to receive XYP injection in combination with standard therapy or receive standard supportive therapy alone. We found that XYP injection significantly reduced the time to cough relief, fever resolution and virus clearance. Less patients receiving XYP injection experienced disease progression to the severe stage during the treatment process. No severe adverse events were reported during the study. Taken together, XYP injection is safe and effective in improving the recovery of patients with mild to moderate COVID-19. However, further studies are warranted to evaluate the efficacy of XYP in an expanded cohort comprising COVID-19 patients at different disease stages.
CONFLICT OF INTEREST The authors declare no conflicts of interest.
AUTHOR CONTRIBUTIONS Xiao-Qun Ye, Xin-Yi Zhang and Lang Lv: Designed the experiment. Xiao-Qun Ye, Xin-Yi Zhang, Lang Lv, Yu-Long Zhou and Liang-Dong Xie: Collected the data. Qin Xu, Xiao-Fan Zou, Yan Ding, Jie Tian, Jia-Liang Fan, Hai-Wei Fan and Yi-Xi Yang: Contributed to data analysis. All authors contributed toward data analysis, drafting and revising the paper and agree to be accountable for all aspects of the work.
ETHICS STATEMENT The study on human participants was approved by the institutional review board or ethics committee at each participating site. Written informed consent was obtained from all the patients.
SUPPORTING INFORMATION Additional supporting information may be found online in the Supporting Information section at the end of this article.
References
Boulware, Pullen, Bangdiwala, Pastick, Lofgren et al., A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19, The New England Journal of Medicine,
doi:10.1056/NEJMoa2016638Cao, Wang, Wen, Liu, Wang et al., A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, The New England Journal of Medicine,
doi:10.1056/NEJMoa2001282Chandramohan, Kaphle, Chekuri, Gangarudraiah, Bychapur Siddaiah, Evaluating andrographolide as a potent inhibitor of NS3-4A protease and its drug-resistant mutants using in silico approaches, Advances in Virology,
doi:10.1155/2015/972067Chang, Ding, Chen, Pan, Zhao et al., Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus,
doi:10.3181/00379727-197-43225Chong, Chen, Luo, Jiang, Simultaneous determination of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate in rat plasma by UHPLC-ESI-MS/MS after administration of xiyanping injection: Application to a pharmacokinetic study, Biomedical Chromatography,
doi:10.1002/bmc.2866Enmozhi, Raja, Sebastine, Joseph, Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach, Journal of Biomolecular Structure & Dynamics,
doi:10.1080/07391102.2020.1760136Guo, Liu, Chen, Hong, Qian et al., Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-κB pathways, International Immunopharmacology,
doi:10.1016/j.intimp.2012.09.002Hu, Guan, Bi, Zhang, Li et al., Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial, Phytomedicine,
doi:10.1016/j.phymed.2020.153242Huang, Bai, He, Xie, Zhou, Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19), Pharmacological Research,
doi:10.1016/j.phrs.2020.104939Li, He, Tang, Ding, Chu et al., Andrographolide inhibits inflammatory cytokines secretion in LPSstimulated RAW264.7 cells through suppression of NF-κB/MAPK signaling pathway. Evidence-based Complementary and Alternative Medicine,
doi:10.1155/2017/8248142Li, Li, Zhang, Guo, Xu et al., Xiyanping plus azithromycin chemotherapy in pediatric patients with mycoplasma pneumoniae pneumonia: A systematic review and metaanalysis of efficacy and safety, Evidence-based Complementary and Alternative Medicine,
doi:10.1155/2019/2346583Li, Yang, Guan, Wen, Duan et al., Andrographolide sulfonate reduces mortality in Enterovirus 71 infected mice by modulating immunity, International Immunopharmacology,
doi:10.1016/j.intimp.2017.11.042Lin, Chen, Duh, Chang, Liu, Inhibition of the epstein-barr virus lytic cycle by andrographolide, Biological & Pharmaceutical Bulletin,
doi:10.1248/bpb.31.2018Peng, Zhou, Ding, Li, Yao, Modulation of lianbizi injection
Raja, Prabahar, Selvakumar, Raja, In silico analysis to compare the effectiveness of assorted drugs prescribed for swine flu in diverse medicine systems, Indian Journal of Pharmaceutical Sciences
Reddy, Reddy, Ravikanth, Krishnaiah, Goud et al., A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity, Natural Product Research,
doi:10.1080/14786410410001709197Seubsasana, Pientong, Ekalaksananan, Thongchai, Aromdee, A potential andrographolide analogue against the replication of herpes simplex virus type 1 in vero cells, Medicinal Chemistry,
doi:10.2174/157340611795564268Sheeja, Kuttan, Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide, Immunopharmacology and Immunotoxicology,
doi:10.1080/08923970701282726Sheeja, Kuttan, Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice, Integrative Cancer Therapies,
doi:10.1177/1534735406298975Shi, Guo, Zhu, Li, Ung et al., Cost-effectiveness analysis of Xiyanping injection (andrographolide sulfonate) for treatment of adult community acquired pneumonia: A retrospective, propensity score-matched cohort study, Evidence-Based Complementary and Alternative Medicine,
doi:10.1155/2019/4510591Tang, Cao, Han, Wang, Chen et al., Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial, BMJ,
doi:10.1136/bmj.m1849Wang, Xie, Adverse event case reports for Xiyanping injection based on literature], Zhongguo Zhong Yao Za Zhi,
doi:10.4268/cjcmm20121830Xiong, Wang, Liu, Chen, Zheng et al., Effect of the combination of Xiyanping and Cefazolin on the function of neutrophils in mice], Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Yang, Li, Zhang, Xu, Yang et al., Crystal structure and anti-inflammatory and anaphylactic effects of andrographlide sulphonate E in Xiyanping, a traditional Chinese medicine injection, The Journal of Pharmacy and Pharmacology,
doi:10.1111/jphp.13028Zhang, Li, Li, Wong, Wang et al., Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism, Phytomedicine,
doi:10.1016/j.phymed.2020.153297Zheng, Shao, Chen, Luo, In vitro metabolism of sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate in rat liver S9 by liquid chromatography-mass spectrometry method, Pharmacognosy Magazine,
doi:10.4103/0973-1296.182194Zhuang, Fan, Chu, Wang, Yang et al., Chinese patent medicines in the treatment of Coronavirus Disease 2019 (COVID-19) in China, Frontiers in Pharmacology,
doi:10.3389/fphar.2020.01066
